Search by Drug Name or NDC

    NDC 00955-1727-20 OXALIPLATIN 5 mg/mL Details

    OXALIPLATIN 5 mg/mL

    OXALIPLATIN is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Winthrop U.S, a business of sanofi-aventis U.S. LLC. The primary component is OXALIPLATIN.

    Product Information

    NDC 00955-1727
    Product ID 0955-1727_0bef4471-e36c-83e6-e063-6294a90a6a5d
    Associated GPIs 21100028002030
    GCN Sequence Number 059163
    GCN Sequence Number Description oxaliplatin VIAL 100MG/20ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24701
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name OXALIPLATIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION, CONCENTRATE
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Winthrop U.S, a business of sanofi-aventis U.S. LLC
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021759
    Listing Certified Through 2024-12-31

    Package

    NDC 00955-1727-20 (00955172720)

    NDC Package Code 0955-1727-20
    Billing NDC 00955172720
    Package 1 VIAL, GLASS in 1 CARTON (0955-1727-20) / 20 mL in 1 VIAL, GLASS
    Marketing Start Date 2014-07-07
    NDC Exclude Flag N
    Pricing Information N/A